Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyanamide SCHEMBL10579212 | 0.90 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL8029393 | 0.79 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL4117115 | 0.79 | TSHR (0.32) | TSHR | |
| SCHEMBL8035177 | 0.76 | ALDH1A1 (0.40) | ALDH1A1TSHR | |
| SCHEMBL5501020 | 0.73 | ALDH1A1 (0.38) | ALDH1A1 | |
| SCHEMBL8019676 | 0.73 | ALDH1A1 (0.38) | ALDH1A1 | |
| SCHEMBL1078494 | 0.73 | ALDH1A1 (0.34) | ALDH1A1TSHR | |
| SCHEMBL316855 | 0.73 | ALDH1A1 (0.44) | ALDH1A1TSHR | |
| SCHEMBL50299 | 0.72 | ALDH1A1 (0.48) | ALDH1A1TSHR | |
| SCHEMBL29377653 | 0.72 | ALDH1A1 (0.48) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2888044-A1 | POLYMERIC AND SOLID-SUPPORTED CATALYSTS, AND METHODS OF DIGESTING CELLULOSIC MATERIALS USING SUCH CATALYSTS | Midori Renewables, Inc. (US) | 2015-07-01 | — | — | EP | disclosed |
| WO-2014031956-A1 | POLYMERIC AND SOLID-SUPPORTED CATALYSTS, AND METHODS OF DIGESTING CELLULOSIC MATERIALS USING SUCH CATALYSTS | Midori Renewables, Inc. (US) | 2014-02-27 | — | — | WO | disclosed |
| EP-1429993-B1 | USES OF IMPROVED POLYMER-SUPPORTED PHOTOSENSITIZERS IN THE GENERATION OF SINGLET OXYGEN | LUMIGEN INC (US) | 2011-01-26 | — | — | EP | disclosed |
| EP-1432640-B1 | POLYMER-SUPPORTED PHOTOSENSITISERS | LUMIGEN INC (US) | 2009-01-14 | — | — | EP | disclosed |
| EP-1429993-A4 | USES OF IMPROVED POLYMER-SUPPORTED PHOTOSENSITIZERS IN THE GENERATION OF SINGLET OXYGEN | LUMIGEN INC (US) | 2008-08-13 | — | — | EP | disclosed |
| EP-1432640-A4 | IMPROVED POLYMER-SUPPORTED PHOTOSENSITIZERS | LUMIGEN INC (US) | 2005-05-04 | — | — | EP | disclosed |
| US-6774249-B2 | CROSSLINKED POLYMER BACKBONE TO WHICH IS BOUND A PLURALITY OF PHOTOSENSITIZER GROUPS AND A PLURALITY OF CATIONIC +NR3 OR PR3+ GROUPS | LUMIGEN, INC. | 2004-08-10 | — | — | US | disclosed |
| EP-1432640-A2 | IMPROVED POLYMER-SUPPORTED PHOTOSENSITIZERS | LUMIGEN, INC. (US) | 2004-06-30 | — | — | EP | disclosed |
| EP-1429993-A1 | USES OF IMPROVED POLYMER-SUPPORTED PHOTOSENSITIZERS IN THE GENERATION OF SINGLET OXYGEN | LUMIGEN, INC. (US) | 2004-06-23 | — | — | EP | disclosed |
| US-20030095916-A1 | Uses of improved polymer-supported photosensitizers in the generation of singlet oxygen | LUMIGEN, INC. | 2003-05-22 | — | — | US | disclosed |
| US-6545102-B1 | Polymer-immobilized photosensitizers comprise a cross-linked polymer backbone, a plurality of cationic ammonium or phosphonium groups covalently bound to the polymer backbone and an immobilized photosensitizer. | LUMIGEN, INC. | 2003-04-08 | — | — | US | disclosed |
| WO-2003027004-A2 | IMPROVED POLYMER-SUPPORTED PHOTOSENSITIZERS | LUMIGEN, INC. (US) | 2003-04-03 | — | — | WO | disclosed |
| WO-2003027007-A1 | USES OF IMPROVED POLYMER-SUPPORTED PHOTOSENSITIZERS IN THE GENERATION OF SINGLET OXYGEN | LUMIGEN, INC. (US) | 2003-04-03 | — | — | WO | disclosed |
| EP-0561033-B1 | Polymeric phoshonium salts providing enhanced chemiluminescence from 1,2-dioxetanes, and their use. | LUMIGEN INC (US) | 2000-03-15 | — | — | EP | disclosed |
| US-5439617-A | Composition containing stable 1,2-dioxetane, polyvinyl phosphonium salt polymer | LUMIGEN, INC. (US) | 1995-08-08 | — | — | US | disclosed |
| US-5431845-A | Polymeric phosphonium salts providing enhanced chemiluminescence from 1,2-dioxetanes | LUMIGEN, INC. (US) | 1995-07-11 | — | — | US | disclosed |
| US-5393469-A | Triggering dioxetane with activating agents consisting of acids, bases, salts, enzymes, inorganic or organic catalysts and electron donors; used for immunoassay and nucleic acid assay | LUMIGEN, INC. (US) | 1995-02-28 | — | — | US | disclosed |
| EP-0561033-A1 | Polymeric phoshonium salts providng enhanced chemiluminescence from 1,2-dioxetanes | LUMIGEN, INC. (US) | 1993-09-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030095916-A1 | Uses of improved polymer-supported photosensitizers in the generation of singlet oxygen | PPOX, ACP1, LCP1 | ALDH1A1 2672/4885TSHR 4671/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.